Molecular characterization of methicillin-resistant Staphylococcus aureus isolated from a Brazilian university hospital  by Martins, André et al.
BM
S
u
A
M
a
b
S
a
A
R
A
A
K
S
M
S
B
S
h
a
c
i
B
a
c
t
r
S
1
hb r a z j i n f e c t d i s . 2 0 1 4;1  8(3):331–335
The Brazilian Journal of
INFECTIOUS  DISEASES
www.elsev ier .com/ locate /b j id
rief communication
olecular  characterization  of methicillin-resistant
taphylococcus aureus  isolated  from  a Brazilian
niversity hospital
ndré Martinsa,b, Danilo Flávio Moraes Riboli a, Valéria Cataneli Pereiraa,
aria de Lourdes Ribeiro de Souza da Cunhaa,∗
Department of Microbiology and Immunology, Biosciences Institute, UNESP – Univ Estadual Paulista, São Paulo, Brazil
Department of Tropical Diseases and Imaging Diagnosis, Botucatu School of Medicine, UNESP – Univ Estadual Paulista,
ão  Paulo, Brazil
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 6 February 2013
ccepted  15 November 2013
vailable  online 3 January 2014
eywords:
taphylococcus aureus
a  b  s  t  r  a  c  t
The aim of this study was to perform SCCmec typing in Staphylococcus aureus isolates and
to  characterize the clonal proﬁle of these isolates. Forty-six mecA gene-positive strains iso-
lated between 2002 and 2006 were submitted to antimicrobial resistance testing by the E-test,
SCCmec  typing by multiplex PCR, and clonal proﬁle analysis by pulsed-ﬁeld gel electrophore-
sis.  Forty-one (89.1%) isolates were typed as SCCmec III and ﬁve (10.9%) as SCCmec IV. Four
circulating  clones were detected, one of them comprising isolates related to the Brazilian
epidemic  clone. This clone was detected throughout the study period. The SCCmec III iso-RSA
CCmec
EC
lates  were associated with a high rate of multidrug resistance and clonal dissemination of
methicillin-resistant S. aureus in the wards of the University Hospital of the Botucatu School
of Medicine, Universidade Estadual Paulista.
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© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDtaphylococcus aureus is a major human pathogen, which
as  been related to numerous pathological processes, such
s  food poisoning, pneumonia, bacteremia, impetigo, folli-
ulitis,  and osteomyelitis.1 At present, this microorganism
s the main causative agent of nosocomial infections. In
razil,  approximately 20% of bacteremias are caused by S.
ureus.2 Similar rates have been reported in several European
ountries, indicating that it is important to study the role of
3,4his  microorganism in healthcare-associated infections.
Oxacillin is used as a resistance marker for methicillin-
esistant S. aureus (MRSA), since strains resistant to oxacillin
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Este é um artigo Open Access sob a licençaare often multiresistant. Approximately 30–50% of hospital
S.  aureus isolates are oxacillin-resistant, a fact that leaves
few  treatment options.5–7 The mecA gene is the main mech-
anism  responsible for methicillin resistance. This gene is
carried  by the cassette chromosome mec (SCCmec),  a movable
genetic  element that consists of incision and excision genes
(ccr  complex), in addition to genes that encode resistance to
antimicrobials and heavy metals.8 Eleven different SCCmec, Instituto de Biociências, UNESP – Universidade Estadual Paulista,
 (M. de Lourdes Ribeiro de Souza da Cunha).
types  have been described so far, which differ in terms of
the  number of genes that they carry and gene architecture. In
addition, different SCCmec types are associated with hospital
 de CC BY-NC-ND
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or community isolates, a fact making SCCmec typing an impor-
tant  epidemiological tool.10 Some of these SCCmec types carry
genes  encoding multidrug resistance, including resistance
to  beta-lactams, macrolides, lincosamines, streptogramins,
aminoglycosides, and tetracycline. Hence, if a bacterial cell
acquires  such SCCmec, it concomitantly acquires a multidrug
resistance phenotype.11
In Brazil, oxacillin resistance rates are high, with an
incidence of 30–50% depending on the region studied.12–14
However, little is known about the dissemination of these
clonal  isolates, although studies on the clonal proﬁle of MRSA
infections  have been conducted in other countries. Five large
pandemic  clones of MRSA isolates have been identiﬁed by
epidemiological techniques. Recent ﬁndings permitted us to
conﬁrm important changes in the epidemiology of MRSA
infections in Brazilian hospitals. At the beginning of the past
decade,  the Brazilian epidemic clone (BEC)/type III/ST239 was
the  main lineage in Brazilian hospitals.15 Over recent years,
type  IV isolates have emerged in hospital settings and have
become  a common type of MRSA found in inpatients world-
wide.  Studies conducted in Rio de Janeiro, Brazil, identiﬁed
USA400/type IV/ST1 followed by USA800/ST5 as the main
lineages.16–19 Antimicrobial resistance and virulence factors
are  unique to each clone.
Since oxacillin resistance has become a major problem in
hospitals  which leaves few therapeutic options and since the
presence  of pandemic clones indicates clonal dissemination
of  MRSA isolates, the aim of the present study was to per-
form  molecular characterization of MRSA strains isolated from
the University Hospital of the Botucatu School of Medicine
(HCFMB), UNESP.
Forty-six mecA gene-positive S. aureus strains (MRSA) iso-
lated  from blood cultures of patients hospitalized in different
wards  of HCFMB-UNESP between 2002 and 2006 and stored
in  the culture collection of the Department of Microbiology
and Immunology, UNESP, were  studied. The strains were iso-
lated using the standard microbiological techniques described
by  Koneman et al.20 In this study, the isolates of the 30
HCFMB-UNESP wards  were divided into complexes accord-
ing  to specialties: Internal Medicine Wards, Surgery Wards,
Pediatric  Wards, Gynecology and Obstetrics, Emergency Room,
Intensive  Care Units, and other wards.
The in vitro susceptibility of the isolates to the follow-
ing  drugs was  tested: oxacillin, netilmicin, erythromycin,
sulfamethoxazole-trimethoprim, and vancomycin. For this
purpose,  the minimal inhibitory concentration (MIC) of these
drugs  was  determined by the E-test. The isolates were  clas-
siﬁed  as sensitive or resistant according to the cut-off levels
(g/mL)  recommended by the CLSI.21
SCCmec typing was  performed by multiplex PCR as
described by Milheiric¸o  et al.22 The S. aureus isolates were
typed  by PFGE according to the modiﬁed protocol of McDougal
et  al.23 Among the 46 mecA gene-positive S. aureus isolates,
23  were  selected based on a similar proﬁle of MIC deter-
mined with the E-test strip. The isolates were divided into
groups  according to the MIC  obtained for all antimicrobial
agents tested and one isolate representative of each group
was  selected. All S. aureus strains carrying SCCmec type IV
were  submitted to typing by PFGE. SmaI (Fast Digest SmaI,
Fermentas Life Science, Canada) was  used for genomic DNA 1 4;1  8(3):331–335
restriction.  Electrophoresis was  performed on 1% agarose
gel  prepared with 0.5 M TBE (Pulsed Field Certiﬁed Agarose,
BioRad  Laboratories, USA) using the CHEF-DR III System
(BioRad Laboratories) under the following conditions: pulse
time  interval of 5–40 s for 21 h on a linear ramp; 6 V/cm;
120◦ angle; 14◦ C; 0.5 M TBE as running buffer. Lambda
Ladder PFG Marker (New England BioLabs, UK) was used
as  a molecular weight marker. The gels were stained with
GelRed  (10,000× in water, Biotium, USA) for 1 h and pho-
tographed under UV transillumination. For similarity analysis,
the  Dice correlation coefﬁcient was  estimated and a dendro-
gram  was  created by the UPGMA method (unweighted pair
group  method using arithmetic averages) using the BioNu-
merics  6.1 software (Applied Maths, Belgium). Band position
tolerance and optimization were set at 1.5 and 1%,  respec-
tively.  A similarity coefﬁcient of 80% was  chosen for cluster
deﬁnition.
Among  the 46 mecA gene-positive S. aureus strains isolated
from  blood cultures between 2002 and 2006, 41 (89.1%) were
typed  as SCCmec III and ﬁve (10.9%) as SCCmec  IV. Most (n = 14)
of  the 41 SCCmec III isolates were identiﬁed in the Internal
Medicine complex, followed by nine isolates in other wards,
eight  isolates in the Surgery complex, seven isolates in the
Emergency  complex, two isolates in the Intensive Care Unit
complex,  and one isolate in the Nursery complex. SCCmec  type
IV  was  detected in two isolates from the Emergency complex
and  in one isolate each from the Surgery, Internal Medicine
and  Intensive Care Unit complexes.
Resistance to the drugs tested varied according to
SCCmec type. A higher percentage of isolates resis-
tant to erythromycin (n = 40), netilmicin (n = 38) and
trimethoprim–sulfamethoxazole (n = 39) was  observed among
SCCmec  III MRSA. An association was observed between
multidrug resistance and presence of the SCCmec III cassette,
with  38 (92.7%) isolates being resistant to three of the four
drugs  tested and only one isolate being resistant to two, one
and  none of the drugs, respectively. Four of the ﬁve SCCmec IV
isolates were susceptible to the drugs tested and one strain
was  resistant to erythromycin. SCCmec III MRSA predomi-
nated  in all years studied; however, SCCmec IV isolates were
not  detected in 2005.
Susceptibility  to vancomycin varied according to SCCmec
cassette type. The MIC50 and MIC90 of vancomycin for SCCmec
IV  isolates were 2 and 3 g/mL, respectively. These values were
higher  than those obtained for SCCmec III isolates (1.5 and
2  g/mL, respectively). No decrease in vancomycin suscepti-
bility  was observed in SCCmec III and IV isolates over the study
period.  Among SCCmec III isolates, the MIC50 of vancomycin
showed a slight decrease from 2002 (2 g/mL) to 2003 (1 g/mL),
followed  by a slight increase in 2004 (1.5 g/mL), and remained
stable  in 2005 and 2006 (2 g/mL). For SCCmec IV isolates, MIC
values  decreased from 2002 to 2003 and remained stable in
subsequent  years.
Analysis  of SCCmec III isolates by PFGE revealed the pres-
ence  of four clones. These clones were  divided based on a
similarity  coefﬁcient ≥80% and identiﬁed with capital letters.
There  was  a predominance of clone A, comprising ﬁve iso-
lates.  When all isolates were analyzed, 16 S. aureus strains
isolated from the Internal Medicine, Surgery, Emergency and
other  wards  complexes were included in this clone (Table 1
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Table 1 – Distribution of clones of MRSA isolates carrying SCCmec type III according to ward complex.
Ward complex
Surgery Internal medicine Other wards Emergency ICU
N % N % N % N % N %
Clone A 5 100 3 42.9 6 75 1 25 1 50
Clone B 0 0 1 14.3 0 0 1 25 0 0
Clone C 0 0 2 28.6 1 12.5 2 50 1 50
Clone D 0  0 1 14.3 1 12.5 0 0 0 0
Total 5 100 7 100 8 100 4 100 2 100
Clone: identiﬁed in the dendrogram of SCCmec type III Staphylococcus aureus generated by Dice/UPGMA analysis (Bionumerics, Applied Maths)
of PFGE proﬁles (SmaI) (similarity ≥80%).
N: number of MRSA isolates belonging to the respective clone.
Surgery complex: surgery, cardiac surgery, thoracic surgery, gastric surgery, orthopedic surgery, and urologic surgery wards.
Internal medicine: dermatology, gastrointestinal clinic, internal medicine, intensive care unit, cardiology, cardiology clinic, hematology and
pulmonology wards.
Other  wards: chemotherapy, oncology, infectious and parasitic diseases, neurology, and dialysis wards.
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nd Fig. 1). This clone predominated in the Surgery and other
ards  complexes.
The  reference strain HU 25 CEB, which belongs to the Brazil-
an  clone of pandemic circulation (BEC), was  also included in
lone  A, suggesting a relationship between these isolates and
he  Brazilian epidemic clone. Strains isolated between 2002
nd  2006 were  included in this clone (Fig. 1). Clone B com-
rised  two strains isolated from the Internal Medicine and
mergency  complexes between 2002 and 2004 (Table 1 and
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ig. 1 – Dendrogram of SCCmec type III Staphylococcus aureus isol
pplied Maths) of PFGE proﬁles (SmaI) (similarity ≥ 80%) and com
ype III. The international clones were  kindly provided by Dr. An
icrobiologia Clínica, Disciplina de Infectologia, Universidade Fe
gnes Marie  Sá Figueiredo, Instituto de Microbiologia Prof. Pauloe unit and coronary intensive care unit.
Fig.  1). Clone C comprised three isolates (Fig. 1). However, anal-
ysis  of MIC by the E-test resulted in the inclusion of six strains
isolated  in 2002, 2004, 2005 and 2006 from the Intensive Care
Unit,  Emergency and other wards complexes in clone C, with
a  higher prevalence in the Internal Medicine and Emergency
complexes (Table 1 and Fig. 1). Clone D comprised only two
strains  isolated in 2006 from the Internal Medicine and other
wards  complexes (Table 1 and Fig. 1). Twenty isolates exhibited
a  polyclonal proﬁle.
Key SCCmec Complex of wards
Internal medicine
Internal medicine
Internal medicine
Internal medicine
Internal medicine
Internal medicine
Internal medicine
Internal medicine
Emergency
Emergency
Other wards
A
B
C
D
Other wards
Other wards
Pediatric wards
Emergency
Internal medicine
Surgery wards
Surgery wards
Surgery wards
30091/05 III
III
III
IIIa
III
III
III
III
III
III
III
III
III
III
III
III
III
III
III
III
III
III
31597/04
33597/02
HU 25
847/02
30195/04
3373-86/05
32956/04
396/02
31431/04
538/02
30139/04
1369/02
30151/05
85/2082
ANS 46
932/06
1308/06
1594/06
326/06
358/02
30052/05
ates generated by Dice/UPGMA analysis (Bionumerics,
parison with international MRSA clones harboring SCCmec
tonio Carlos Campos Pignatari, Laboratório Especial de
deral de São Paulo-Escola Paulista de Medicina, and Dr.
 de Góes, Universidade Federal do Rio de Janeiro, Brazil.
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The SCCmec IV isolates showed low clonality and only two
strains  isolated in 2002 and 2004 from the Internal Medicine
and  Intensive Care Unit complexes could be clustered.
The present study showed a predominance of the SCCmec
III  cassette in S. aureus. This fact emphasizes the importance
of  appropriate antibiotic therapy since nosocomial Staphylo-
coccus  spp. isolates are known to be associated with multidrug
resistance. There was  a strong association between SCCmec
III  isolates and multidrug resistance, which can be explained
by  the nosocomial origin of these isolates. The drug of choice
for  the treatment of infections with multiresistant MRSA and
S.  aureus is vancomycin; however, vancomycin-resistant iso-
lates or isolates with intermediate susceptibility have been
identiﬁed.  There are also studies describing decreased sus-
ceptibility  of hospital isolates to vancomycin.24,25 Decreased
vancomycin susceptibility was  not observed in the present
study,  with the MIC50 and MIC90 values of SCCmec III MRSA
isolates  being stable over the study period. However, an asso-
ciation  between the presence of SCCmec III and isolates with
intermediate vancomycin resistance has been reported.26
Analysis of the prevalence of SCCmec cassette types in
MRSA  isolates over the study period showed an increase in
the  number of SCCmec III from 2002 to 2005, followed by a
decrease  in 2006. The prevalence of SCCmec IV was  low and
stable  between 2002 and 2004 and this type was  detected again
only  in 2006.
In  view of the increase in the number of oxacillin-resistant
Staphylococcus spp. and the emergence of heteroresistant and
vancomycin-resistant isolates, studies investigating the dis-
semination of these isolates in hospitals are needed. PFGE has
been used successfully for this purpose. In the present study,
23  S. aureus isolates were typed by this method. Although
a  high degree of clonality has been reported for Brazilian
nosocomial MRSA,27 only four clones were detected in the
present  study, with the circulation of isolates in various
wards  and prevalence during the studied years. Clone A com-
prised  the largest number of SCCmec III isolates, which were
isolated  between 2002 and 2006 from the following ward  com-
plexes:  Surgery, Internal Medicine, other wards, Emergency,
and  Intensive Care Unit. The HU 25 strain, which belongs to
BEC,  showed a similarity of more  than 80% to clone A. Hence,
all  isolates belonging to clone A are related to BEC. The Brazil-
ian  clone predominates in hospitals in all regions of Brazil, in
South America and in some European countries such as Por-
tugal,  accounting for 70% of MRSA isolated from hospitals.15 A
high prevalence of BEC-like isolates was  detected in hospitals
in  the northeastern and southeastern regions of Brazil.28,29 In
the  present study, isolates belonging to clone A were identi-
ﬁed  in all years studied, a ﬁnding that can be explained by
the  fact that clone A has been the predominant clone in vari-
ous  Brazilian hospitals since the 1990s.29,30 Although the clone
related  to BEC has been the most predominant, its prevalence
was  not homogeneous, since other clones were found in this
study,  which can mean a replacement in the future circulation
of  the BEC clone by other clones.
The isolates characterized as SCCmec IV showed a poly-
clonal  proﬁle. However, PFGE permitted the identiﬁcation of a
clone that disseminated in 2002 and 2004. Isolates of this clone
were  recovered from the Cardiology and Intensive Care Unit
wards.  This clone did not show similarity to strains USA800 or 1 4;1  8(3):331–335
HAR24, which belong to the pediatric and EMRSA-15 clone,
respectively, and are characterized by the presence of the
SCCmec  IV cassette. Although SCCmec IV isolates did not pre-
dominate  in this study, replacement of BEC with EMRSA-15
has  been reported in Portugal.31 A high percentage of SCCmec
IV  MRSA isolates (46%) was described in a Swiss university
hospital, with the predominance of four major clones. This
ﬁnding  can be explained by the replacement of hospital clones
with  pediatric clones in healthcare-associated infections or
by a massive prevalence of isolates of community origin.32 In
Brazil,  three strains genetically related to clone USA800 were
isolated  in the northeastern region, a ﬁnding suggesting the
introduction  of this community-acquired clone into hospital
settings.28 Studies conducted in Rio de Janeiro suggest that, in
Brazil,  USA400/type IV isolates of community origin have grad-
ually  replaced BEC/type III in the hospital environment.16–19
However, only one SCCmec IV S. aureus strain isolated from the
Emergency  ward  showed a similarity of 60.9% with this clone,
indicating  that they are different clones. The high prevalence
of  BEC isolates in the present study might be explained by the
collection  of S. aureus strains included in the study (2002–2006).
Further  studies need to be conducted at this hospital to deter-
mine  whether a change is occurring in the clonal proﬁle of
isolates.
The  present results conﬁrm the importance of the epi-
demiological characterization of MRSA isolates considering
the  high rates of multidrug resistance among nosocomial S.
aureus isolates and clonal dissemination of MRSA isolates in
the wards of HCFMB-UNESP.
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